Skip to content
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Oncology

Where and Why: Locations, Subtypes, and Symptoms of NENs

At a Glance

Neuroendocrine neoplasms (NENs) are either functional (producing hormones) or non-functional. Functional tumors often cause Carcinoid Syndrome, characterized by flushing and diarrhea. NEN symptoms are frequently misdiagnosed as IBS, menopause, or asthma due to their overlapping physical signs.

Where a neuroendocrine neoplasm (NEN) starts in the body and whether it produces hormones significantly shapes your experience with the disease. Because these tumors grow from cells that can produce chemicals, they can create symptoms that feel like many other common conditions, often leading to a long and confusing path to a correct diagnosis.

Functional vs. Non-Functional Tumors

The first major distinction your care team will make is whether your tumor is functional or non-functional:

  • Non-functional tumors (the most common type) do not produce extra hormones [1]. They are often found incidentally during a scan for something else or cause symptoms by growing large enough to press on nearby organs [2].
  • Functional tumors produce and release hormones or other “vasoactive” substances into your bloodstream [3]. These chemicals cause specific physical symptoms, often called “syndromes.”

Common Locations and Their Impact

NENs can appear almost anywhere, but they are most frequently found in two areas:

1. Gastroenteropancreatic (GEP-NENs)

These occur in the digestive system, including the stomach, intestines, and pancreas [4].

  • Small Intestine: Often the source of Carcinoid Syndrome.
  • Pancreas: Can produce specialized functional tumors like insulinomas [5].

2. Lung NENs

Tumors in the lung account for about 20–25% of all NENs [6]. While they can sometimes cause hormonal symptoms, they often present with a persistent cough or wheezing that may be mistaken for asthma or bronchitis [7][8].

Understanding Carcinoid Syndrome

Carcinoid Syndrome occurs when a tumor (usually in the small intestine or lung) releases excess serotonin and other chemicals into the bloodstream [3].

  • The “First-Pass” Effect: Normally, the liver breaks down these chemicals before they reach the rest of the body [9]. Because of this, Carcinoid Syndrome most often occurs when the tumor has spread to the liver, allowing the chemicals to bypass this “filter” and enter the general circulation [10].
  • Classic Symptoms: The hallmark signs are flushing (sudden redness and warmth in the face and neck) and diarrhea [11]. Other signs include wheezing and abdominal pain.
  • Common Triggers: Many patients find that their flushing and diarrhea are triggered by specific daily factors, including alcohol, spicy foods, foods high in amines (like aged cheeses), and physical or emotional stress.
  • Heart Health Impact: Because serotonin can damage heart valves over time, it is highly recommended that patients with functional tumors request a baseline and routine echocardiogram (ECHO) to screen for Carcinoid Heart Disease [12].

Rare Functional Syndromes: Insulinoma

A primary example of a functional pancreatic tumor is the insulinoma. These tumors produce excess insulin, causing your blood sugar to drop dangerously low [5]. This presents as Whipple’s Triad:

  1. Symptoms of low blood sugar (tremors, sweating, confusion, or dizziness) [13].
  2. A documented low blood glucose level.
  3. Immediate relief of symptoms after eating sugar [14].

Why the Delay? The Great Mimic

NEN symptoms are frequently misdiagnosed because they look like common, non-cancerous conditions:

  • IBS: The diarrhea and cramping of a NEN are often mistaken for Irritable Bowel Syndrome [15].
  • Menopause: NEN-related flushing is frequently dismissed as menopausal “hot flashes” [2].
  • Asthma: Wheezing caused by serotonin can lead to a diagnosis of asthma that doesn’t respond to standard inhalers [8].

If you have been struggling with “refractory” (hard-to-treat) symptoms like these, it is essential to discuss the possibility of a functional NEN with your doctor. Correctly identifying these symptoms is a major step toward effective management [15].

Common questions in this guide

What is the difference between a functional and non-functional NEN?
A non-functional NEN does not produce extra hormones and often only causes symptoms if it grows large enough to press on nearby organs. A functional NEN releases hormones into the bloodstream, causing specific physical symptoms known as syndromes.
What are the signs of Carcinoid Syndrome?
The most common signs are sudden flushing in the face and neck, along with diarrhea. Other symptoms can include wheezing and abdominal pain, which are often triggered by specific foods, alcohol, or stress.
Why are neuroendocrine tumor symptoms often misdiagnosed?
NEN symptoms frequently mimic common, non-cancerous conditions. Diarrhea and cramping may be misdiagnosed as Irritable Bowel Syndrome (IBS), flushing is often dismissed as menopausal hot flashes, and wheezing can be mistaken for asthma.
What does it mean if my NEN is in the pancreas?
Pancreatic NENs can sometimes be functional tumors, such as insulinomas. These tumors produce excess insulin, which can cause dangerously low blood sugar levels leading to confusion, sweating, tremors, and dizziness.
Do I need a heart scan if I have Carcinoid Syndrome?
Yes, patients with functional tumors should have a baseline and routine echocardiogram (ECHO). The excess serotonin from the tumor can damage heart valves over time, leading to Carcinoid Heart Disease.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my tumor considered 'functional' or 'non-functional,' and how was that determined?
  2. 2.Should I have a 24-hour urine 5-HIAA test or a blood test for Chromogranin A to check for hormone activity?
  3. 3.Are my symptoms, such as flushing or diarrhea, consistent with Carcinoid Syndrome?
  4. 4.Should I schedule a baseline echocardiogram (ECHO) to screen for Carcinoid Heart Disease?
  5. 5.If I have a lung NEN, are there specific hormonal symptoms I should watch for that differ from a GI NEN?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (15)
  1. 1

    Better Management for Neuroendocrine Neoplasms: A Complex Task Ahead.

    Coriat R

    Journal of clinical medicine 2021; (10(9)) doi:10.3390/jcm10091859.

    PMID: 33922910
  2. 2

    Histopathological Features Predicting Neuroendocrine Morphology in Primary Breast Tumors: A Retrospective Analysis.

    Ozsen M, Senol K, Tolunay S, et al.

    European journal of breast health 2024; (20(2)):110-116 doi:10.4274/ejbh.galenos.2024.2023-12-10.

    PMID: 38571692
  3. 3

    The role of serotonin inhibition within the treatment of carcinoid syndrome.

    George J, Ramage J, White B, Srirajaskanthan R

    Endocrine oncology (Bristol, England) 2023; (3(1)):e220077 doi:10.1530/EO-22-0077.

    PMID: 37434648
  4. 4

    Gastroenteropancreatic neuroendocrine neoplasms: Clinical-pathologic analysis of 48 cases treated at the Hospital Ángeles del Pedregal in Mexico City between 2018 and 2024.

    Sánchez-Arreguín R, Ahumada-Ayala M, Santibañez-Silva V, et al.

    Revista de gastroenterologia de Mexico (English) 2025; (90(4)):520-529 doi:10.1016/j.rgmxen.2025.10.014.

    PMID: 41162247
  5. 5

    A Rare Case of Insulinoma in a Thin, Lean Adult Male: A Case Report.

    Khan Md AR, Wazir MH, Waqar S, et al.

    Cureus 2022; (14(3)):e23414 doi:10.7759/cureus.23414.

    PMID: 35475064
  6. 6

    Sex Differences in the Survival of Patients with Neuroendocrine Neoplasms: A Comparative Study of Two National Databases.

    Mortagy M, El Asmar ML, Chandrakumaran K, Ramage J

    Cancers 2024; (16(13)) doi:10.3390/cancers16132376.

    PMID: 39001438
  7. 7

    Unmasking Carcinoid Syndrome in a Chronic Obstructive Pulmonary Disease (COPD) Patient: A Rare Presentation with Wheezing and Angioedema.

    Aleksanyan M, Chadalawada S, Hakobyan K, et al.

    Cureus 2024; (16(5)):e61321 doi:10.7759/cureus.61321.

    PMID: 38947683
  8. 8

    A 17-year-old male with a Small Bowel Neuroendocrine Tumor: flushing differential diagnosis.

    Forero Molina MA, Garcia E, Gonzalez-Devia D, et al.

    The World Allergy Organization journal 2017; (10(1)):30 doi:10.1186/s40413-017-0161-4.

    PMID: 28904734
  9. 9

    Prediction of the First-Pass Metabolism of a Drug After Oral Intake Based on Structural Parameters and Physicochemical Properties.

    Hosseini MAH, Alizadeh AA, Shayanfar A

    European journal of drug metabolism and pharmacokinetics 2024; (49(4)):449-465 doi:10.1007/s13318-024-00892-6.

    PMID: 38733548
  10. 10

    A case of carcinoid syndrome probably exacerbated by hemodialysis in which prochlorperazine maleate was effective.

    Oda K, Murata T, Tsujimoto K, et al.

    CEN case reports 2024; (13(2)):135-140 doi:10.1007/s13730-023-00814-6.

    PMID: 37606883
  11. 11

    Carcinoid Syndrome: A Review.

    Gade AK, Olariu E, Douthit NT

    Cureus 2020; (12(3)):e7186 doi:10.7759/cureus.7186.

    PMID: 32257725
  12. 12

    Hedinger Syndrome: A Rare Cardiac Manifestation of Carcinoid Syndrome.

    Ghukasyan H

    Cureus 2022; (14(7)):e26528 doi:10.7759/cureus.26528.

    PMID: 35795576
  13. 13

    Approach to the Patient: Insulinoma.

    Hofland J, Refardt JC, Feelders RA, et al.

    The Journal of clinical endocrinology and metabolism 2024; (109(4)):1109-1118 doi:10.1210/clinem/dgad641.

    PMID: 37925662
  14. 14

    Spontaneous hypoglycemia: diagnostic evaluation and management.

    Kandaswamy L, Raghavan R, Pappachan JM

    Endocrine 2016; (53(1)):47-57 doi:10.1007/s12020-016-0902-0.

    PMID: 26951054
  15. 15

    Exploring Carcinoid Syndrome in Neuroendocrine Tumors: Insights from a Multidisciplinary Narrative Review.

    Marasco M, Romano E, Arrivi G, et al.

    Cancers 2024; (16(22)) doi:10.3390/cancers16223831.

    PMID: 39594786

This page is for informational purposes only and does not replace professional medical advice. Always consult your healthcare provider or oncologist for a proper diagnosis and management of NEN symptoms.

Get notified when new evidence is published on Neuroendocrine neoplasm.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.